Is precision medicine gaining traction in the field of oncology? The Food and Drug Administration’s recent approval of the cancer drug pembrolizumab offers a hint.
Some Medicare beneficiaries pay 20 percent of their income in out-of-pocket medical expenses, a new study finds. And a disproportionate number of those are low-income
One in every three new drugs triggers side effects discovered only after Food and Drug Administration approval, new data reveals. And that statistic begs a
By Brian Kennedy, Executive Director of the Global Alliance for Patient Access When should patients switch from one medicine to another for non-medical reasons? How can
“Doctor, make my pain go away.” I hear this plea, in one form or another, from patients on a daily basis. Yet it presents physicians like
What can the federal government do to raise clinical trials awareness? Maybe a lot, suggests one organization. May 1-5 marks Clinical Trials Awareness Week, when
Rejection is never pleasant. But for the 34,459 patients whose health plans refuse to cover advanced treatment for high cholesterol, it could also be deadly.